Stock ADCI THE ARAB DRUG COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials The Arab Drug Company

Equities

ADCI

EGS38321C013

Pharmaceuticals

End-of-day quote Egyptian Exchange
Other stock markets
 18:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
94.19 EGP 0.00% Intraday chart for The Arab Drug Company 0.00% +35.27%
02-14 The Arab Drug Company Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2023 CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 180.2 177.8 353.8 396.9 275 401.1
Enterprise Value (EV) 1 164 162.7 294.6 357.8 385.8 542.7
P/E ratio 6 x 5.47 x 4.72 x 4.82 x 4.07 x 5.64 x
Yield 9.99% 10.5% 4.24% 7.56% - 6.73%
Capitalization / Revenue 0.47 x 0.41 x 0.68 x 0.74 x 0.54 x 0.63 x
EV / Revenue 0.43 x 0.37 x 0.57 x 0.67 x 0.76 x 0.86 x
EV / EBITDA 2.51 x 2.38 x 2.3 x 2.61 x 4.18 x 5.06 x
EV / FCF -13.4 x -18.5 x 4.79 x 117 x -2.98 x -31.5 x
FCF Yield -7.44% -5.42% 20.9% 0.86% -33.5% -3.17%
Price to Book 1.04 x 0.94 x 1.42 x 1.28 x 0.91 x 1.05 x
Nbr of stocks (in thousands) 6,000 6,000 6,000 6,000 6,000 6,000
Reference price 2 30.04 29.64 58.97 66.15 45.84 66.85
Announcement Date 8/29/18 8/29/19 8/27/20 9/1/21 9/7/23 9/7/23
1EGP in Million2EGP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 382.9 436.3 520.8 537 505 633.7
EBITDA 1 65.31 68.3 128.1 136.8 92.35 107.2
EBIT 1 53.28 56.89 117.3 127.1 90.77 97.08
Operating Margin 13.91% 13.04% 22.52% 23.66% 17.97% 15.32%
Earnings before Tax (EBT) 1 53.41 56.1 119.7 131.6 98.3 106.7
Net income 1 39.47 43.1 92.8 102 76.3 82.77
Net margin 10.31% 9.88% 17.82% 19% 15.11% 13.06%
EPS 2 5.010 5.420 12.50 13.73 11.26 11.85
Free Cash Flow 1 -12.2 -8.818 61.48 3.062 -129.4 -17.23
FCF margin -3.19% -2.02% 11.81% 0.57% -25.62% -2.72%
FCF Conversion (EBITDA) - - 48% 2.24% - -
FCF Conversion (Net income) - - 66.25% 3% - -
Dividend per Share 2 3.000 3.100 2.500 5.000 - 4.500
Announcement Date 8/29/18 8/29/19 8/27/20 9/1/21 9/7/23 9/7/23
1EGP in Million2EGP
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 111 142
Net Cash position 1 16.2 15.1 59.2 39.1 - -
Leverage (Debt/EBITDA) - - - - 1.2 x 1.321 x
Free Cash Flow 1 -12.2 -8.82 61.5 3.06 -129 -17.2
ROE (net income / shareholders' equity) 25.6% 25.7% 42.3% 36.5% 23.5% 22.9%
ROA (Net income/ Total Assets) 12.4% 12.4% 21.9% 19.4% 11.1% 9.66%
Assets 1 317.1 347.5 424.4 525.5 686.1 856.7
Book Value Per Share 2 28.90 31.60 41.50 51.60 50.20 63.90
Cash Flow per Share 2 4.750 5.600 12.20 7.740 5.940 8.410
Capex 1 2.5 4.95 2.53 28.9 89.9 63.2
Capex / Sales 0.65% 1.13% 0.49% 5.38% 17.8% 9.97%
Announcement Date 8/29/18 8/29/19 8/27/20 9/1/21 9/7/23 9/7/23
1EGP in Million2EGP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
THE ARAB DRUG COMPANY Stock The Arab Drug Company
+35.27% 12.06M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.37% 588B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 326B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.83% 239B
NOVARTIS AG Stock Novartis AG
+9.93% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.95% 200B
AMGEN INC. Stock Amgen Inc.
+10.77% 167B
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ADCI Stock
  4. Financials The Arab Drug Company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW